Document is current
Any future updates will be listed below
-
Authors
Dibble, Kate E
Rosenberg, Shoshana M
Snow, Craig
Kirkner, Gregory J
Tayob, Nabihah
Contreras, Magnolia
Roma, Noel D
DeGraffinreid, Cecilia R
Nolan, Timiya S
Hershman, Dawn L
Naughton, Michelle
Partridge, Ann H
-
Funding
Funding for this research was provided by:
National Cancer Institute (U01CA246648)
Breast Cancer Research Foundation (BCRF-23-124)
Helen Gurley Brown Presidential Initiative at Dana-Farber Cancer Institute
Susan G. Komen
American Cancer Society (CRP-24-1187963-01-PROF)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 2 January 2025
First Online: 11 January 2025
Declarations
:
: This study was reviewed and approved by the Ohio State University Institutional Review Board (IRB# OSU-21035, protocol date May 21, 2024, version 8). Study coordinators reviewed the consent form, verifying interest, and confirming eligibility with each potential participant.
: Not applicable.
: Dr. Shoshana Rosenberg reports grant funding from Pfizer/Conquer Cancer. Dr. Ann Partridge reports receiving royalties from Wolters Kluwer for authorship of UpToDate and has received research funding from Novartis. The remaining authors have no conflicts of interest to disclose.
